Generix Global Investment
5 NAFDAC-registered products in Nigeria
Independent profile. This page is compiled by Ogbogwu from NAFDAC-registered records and public information. Ogbogwu is not affiliated with Generix Global Investment, and this listing does not imply any endorsement or partnership.
About Generix Global Investment
Generix Global Investment has 5 products registered with NAFDAC for the Nigerian market. The full list below is compiled from the NAFDAC Greenbook — Nigeria's official register of approved products.
Generix Global Investment products registered in Nigeria
All 5 NAFDAC-registered products.
5 of 5 products
| Product | Active ingredient | Strength | Form | NAFDAC No. |
|---|---|---|---|---|
| Linajen-M 2.5/1000 Tablet | Metformin Hydrochloride; Linagliptin | 1000 mg; 2.5 mg | Tablet | A4-100158 |
| Linajen-M 2.5/500 Tablet | Metformin Hydrochloride; Linagliptin | 500 mg; 2.5 mg | Tablet | A4-100159 |
| Pentazocine Injection 30 mg/mL** | Pentazocine (Pentazocine Lactate) | 30 mg/mL | Solution for injection | A4-100946 |
| Progerix Tablet | Dydrogesterone | 10 mg | Tablet | A4-100399 |
| Xyvida Vildagliptin 50 mg Tablets | Vildagliptin | 50 mg | Tablet | A4-100396 |
Is this your company?
If you represent Generix Global Investment, you can claim this page to keep your company details current, or flag anything that needs correcting. Product and NAFDAC registration facts stay independently maintained by Ogbogwu.
Opens a WhatsApp chat with our team, with your message pre-filled.
Sources
- •NAFDAC Greenbook — the official database of products registered with Nigeria's National Agency for Food and Drug Administration and Control. The product list for Generix Global Investment is drawn from active registrations in the Greenbook.